PP.33.17

Autor: D. Jatsuk, Elena Baranova, O. Listopad, Olga Belyaeva, E. Bazhenova, A.O. Konradi, A. Soboleva, Evgeny Shlyakhto, V. Ionin, E. Vasilieva
Rok vydání: 2015
Předmět:
Zdroj: Journal of Hypertension. 33:e433
ISSN: 0263-6352
DOI: 10.1097/01.hjh.0000468740.62125.07
Popis: Objective:Galectin 3 (Gal3) and aldosterone (ALDO) are profibrogenic substances and in patients with heart failure they are increased. Study objective – to evaluate Gal3 and ALDO in patients with metabolic syndrome (MetS) without heart failure and to estimate a correlation with the main components o
Databáze: OpenAIRE